Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/2852
Title: Hepatotoxicity of isotretinoin in patients with acne and Gilbert's syndrome: a comparative study
Authors: Fernández-Crehuet, Pablo
Fernández-Crehuet, José Luis
Mohamed Farouk, Allam
Fernández-Crehuet Navajas, Rafael
metadata.dc.contributor.authoraffiliation: [Fernández-Crehuet,P; Fernández-Crehuet,JL] Dermatology Unit, Alto Guadalquivir Hospital, Andújar, Jaén, Spain [Allam,MF; Fernández-Crehuet Navajas,R] Department of Preventive Medicine and Public Health, University of Cordoba, Cordoba, Spain
Keywords: Enfermedad de Gilbert;Pacientes ambulatorios;Dermatología;Isotretinoína;Andalucía;Andalusian;Estudio comparativo
metadata.dc.subject.mesh: Medical Subject Headings::Health Care
Medical Subject Headings::Diseases
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative
Medical Subject Headings::Disciplines and Occupations::Health Occupations
Medical Subject Headings::Gilbert Disease
Medical Subject Headings::Dermatology
Medical Subject Headings:: Isotretinoin
Issue Date: 2014
Publisher: BMJ Publishing Group
Citation: Fernández-Crehuet P, Fernández-Crehuet JL, Allam MF, et al. Hepatotoxicity of isotretinoin in patients with acne and Gilbert’s syndrome: a comparative study. BMJ Open 2014;4:e004441. doi:10.1136/bmjopen-2013- 004441
Abstract: Objectives: The objective of our follow-up study is to evaluate liver function tests (LFTs) and lipid profiles in patients with Gilbert’s syndrome treated with isotretinoin because of severe acne. Setting: Dermatology outpatient clinics of three regional hospitals of Jaén (Spain). Participants: Over 4 years, we included all patients diagnosed with severe acne. Only 37 patients were identified, of which 11 had Gilbert’s syndrome. Interventions: All patients were treated with isotretinoin and followed-up in our outpatient clinics after 10 and 20 weeks. Patients were subjected to an interview questionnaire which included data on age, gender, complete blood count, coagulation profile, fasting blood glucose, LFTs and lipid profiles. Data and results of patients with severe acne and Gilbert’s syndrome were compared with those of 26 patients with only severe acne (control group). Primary outcome: Blood analyses were repeated in the follow-up visits. Results: In patients with Gilbert’s syndrome, bilirubin levels showed substantial decrease over the 20-week follow-up, with more decrease after 10 weeks. None of the control group patients had significant increase in total bilirubin levels after 10 and 20 weeks of followup. Liver enzymes were maintained within normal levels in both groups. Both study groups did not show significant pathological increase in lipid profile levels. LDL levels were increased in the two study groups, but this increase was less substantial in patients with Gilbert’s syndrome. Conclusions: Our preliminary results suggest that oral isotretinoin could be an effective, safe treatment for patients with Gilbert’s syndrome, and may lower bilirubin levels in the first 10 weeks of treatment. Limitations of the study include the small numbers of participants and the fact that it is restricted to one region of Spain.
URI: http://hdl.handle.net/10668/2852
metadata.dc.relation.publisherversion: http://bmjopen.bmj.com/content/4/3/e004441
metadata.dc.identifier.doi: 10.1136/bmjopen-2013-004441
ISSN: 2044-6055 (Online)
Appears in Collections:01- Artículos - APES Hospital Alto Guadalquivir

Files in This Item:
File Description SizeFormat 
Fernandez_HepatotoxicityOfIsotretinoin.pdfArticulo publicado415,98 kBAdobe PDFView/Open


This item is protected by original copyright



Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.